Iterum Therapeutics (ITRM)
1.23
0.06 (5.13%)
At close: Apr 02, 2025, 3:59 PM
1.24
1.10%
After-hours: Apr 02, 2025, 07:50 PM EDT
Iterum Therapeutics Balance Sheet Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Cash & Equivalents | 24.13M | 6.07M | 21.09M | 27.45M | 14.51M | 4.8M | 44.55M | 8.48M | 24.81M |
| Short-Term Investments | n/a | 17.86M | 39.75M | 53.94M | 2.36M | 1.14K | 40M | 30.73M | 404K |
| Long-Term Investments | n/a | n/a | -35K | 64K | 248K | 60K | 959K | n/a | n/a |
| Other Long-Term Assets | 39K | 63K | 4.21M | 6.64M | 17.61M | 20.32M | 11.54M | 1.84M | 1.05M |
| Receivables | n/a | 233K | n/a | 1.21M | 865K | 1.1M | 721K | 509K | 245K |
| Inventory | n/a | n/a | -1.85M | -3.13M | -3.74M | -8.03M | -7.87M | n/a | n/a |
| Other Current Assets | 662K | n/a | n/a | 37K | 5.24M | 2.37M | 959K | 180K | n/a |
| Total Current Assets | 24.79M | 25.6M | 60.84M | 81.34M | 14.51M | 4.8M | 84.67M | 44.17M | 25.86M |
| Property-Plant & Equipment | 23K | 600K | 69K | 91K | 421K | 572K | 700K | 747K | n/a |
| Goodwill & Intangibles | 19.75M | n/a | 1.72M | 3.44M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 19.81M | 663K | 6M | 10.16M | 18.28M | 20.95M | 13.2M | 2.58M | 1.05M |
| Total Assets | 44.59M | 26.26M | 66.83M | 91.51M | 32.79M | 25.75M | 97.87M | 46.76M | 26.92M |
| Account Payables | 251K | 5M | 2.77M | 878K | 816K | 15.49M | 4.04M | 3.15M | 1.48M |
| Deferred Revenue | n/a | n/a | -332K | -2.5M | -7.3M | 12.66M | 113K | n/a | n/a |
| Short-Term Debt | n/a | n/a | n/a | 1.63M | 6.49M | 5.8M | 1.02M | n/a | n/a |
| Other Current Liabilities | 17.35M | 761K | 1.94M | 9.05M | 32.46M | 3.04M | 5.24M | 2.92M | 1.95M |
| Total Current Liabilities | 17.61M | 13.52M | 196K | 6.06M | 28.86M | 36.99M | 12.22M | 7.13M | 4.22M |
| Long-Term Debt | 31.07M | 18.96M | 28.47M | 24.9M | 35.85M | 7.63M | 13.08M | n/a | n/a |
| Other Long-Term Liabilities | n/a | 188K | n/a | 3.44M | 630K | 630K | 951K | 137K | 30K |
| Total Long-Term Liabilities | 31.07M | 19.14M | 38.64M | 35.22M | 54.49M | 51.99M | 26.25M | 137K | 30K |
| Total Liabilities | 48.68M | 32.66M | 38.83M | 41.27M | 83.35M | 51.99M | 26.25M | 7.26M | 4.25M |
| Total Debt | 45.53M | 18.96M | 28.47M | 24.9M | 35.85M | 7.63M | 13.08M | n/a | n/a |
| Common Stock | 315K | 135K | 126K | 1.83M | 494K | 149K | 144K | 4K | 4K |
| Retained Earnings | -486.07M | -461.3M | -422.93M | -378.49M | -286.93M | -234.92M | -131.79M | -54.74M | -25.33M |
| Comprehensive Income | n/a | 1K | -350K | n/a | n/a | n/a | -201K | -65K | -0.00 |
| Shareholders Equity | -4.08M | -6.4M | 28M | 50.23M | -50.56M | -26.24M | 71.62M | 39.49M | 22.67M |
| Total Investments | n/a | 17.86M | 39.71M | 53.94M | 248K | 60K | 40.96M | 30.73M | 404K |